CFB
COLL icon

Cullen/Frost Bankers’s Collegium Pharmaceutical COLL Stock Holding History

Cullen/Frost Bankers’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12K Buy
362
+40
+12% +$1.69K ﹤0.01% 1077
2025
Q4 		$14.9K Buy
+322
New +$13.5K ﹤0.01% 1067

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Cullen/Frost Bankers's COLL Position: Q1 2026 in Review

Cullen/Frost Bankers increased its Collegium Pharmaceutical (COLL) stake by 12% in Q1 2026, buying an estimated $1.69K and bringing the position to 362 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

Cullen/Frost Bankers first reported a position in COLL in Q4 2025 and has held it in 2 quarters since. The position peaked at $14.9K in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Cullen/Frost Bankers held 362 shares of Collegium Pharmaceutical worth $12K as of Q1 2026.
  • Cullen/Frost Bankers bought 40 Collegium Pharmaceutical shares in Q1 2026, an estimated $1.69K.
  • Collegium Pharmaceutical made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q1 2026, its #1077 holding.
  • Cullen/Frost Bankers first reported a position in Collegium Pharmaceutical in Q4 2025 and has held it in 2 quarters since.
  • Cullen/Frost Bankers's Collegium Pharmaceutical position peaked at $14.9K in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.